Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells

Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells

Bibliographic Details
Main Authors: Baocheng Gong, Jinhua Zhang, Zhongyan Hua, Zhihui Liu, Carol J. Thiele, Zhijie Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
neuroblastoma
ataxin-3
BIM
Bcl-xl
perifosine
MK-2206
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.984514/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.984514/full

Similar Items